Innovative Medicines

Innovative Medicines Group (IMG) is a specialty pharmaceutical company dedicated to improving access to innovative therapies for rare and high-burden diseases across Latin America. The company operates as a regional partner for global biopharmaceutical firms, providing comprehensive services in licensing, regulatory registration, market access, and commercial distribution. IMG focuses on orphan drugs and niche specialty medicines, particularly in the fields of metabolic disorders, oncology, and hematology. With a strong presence in key markets such as Brazil, Argentina, and Mexico, the group aims to address significant unmet medical needs for small patient populations through strategic alliances and managed access programs.